CNPAX
Price
$73.87
Change
-$0.04 (-0.05%)
Updated
Sep 2 closing price
Net Assets
165.87B
GFFDX
Price
$88.56
Change
+$0.88 (+1.00%)
Updated
Sep 3 closing price
Net Assets
551.17M
Interact to see
Advertisement

CNPAX vs GFFDX

CNPAX vs GFFDX Comparison Chart in %
View a ticker or compare two or three
VS
CNPAX vs. GFFDX commentary
Sep 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNPAX is a StrongBuy and GFFDX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CNPAX has more cash in the bank: 166B vs. GFFDX (551M). CNPAX pays higher dividends than GFFDX: CNPAX (0.95) vs GFFDX (0.00). CNPAX was incepted earlier than GFFDX: CNPAX (25 years) vs GFFDX (7 years). GFFDX (0.87) is less costly to investors than CNPAX (0.74). CNPAX is a more actively managed with annual turnover of: 23.00 vs. GFFDX (17.00). CNPAX has a lower initial minimum investment than GFFDX: CNPAX (250) vs GFFDX (1000000). CNPAX annual gain was more profitable for investors over the last year : 7.24 vs. GFFDX (0.39). CNPAX return over 5 years is better than : 10.16 vs. GFFDX (-2.19).
CNPAXGFFDXCNPAX / GFFDX
Total Expense Ratio0.740.8785%
Annual Report Gross Expense Ratio0.740.8785%
Fund Existence25 years7 years-
Gain YTD6.5957.88084%
Front Load4%N/A-
Min. Initial Investment25010000000%
Min. Initial Investment IRAN/AN/A-
Net Assets166B551M30,127%
Annual Yield % from dividends0.950.00-
Returns for 1 year7.240.391,855%
Returns for 3 years38.4139.0398%
Returns for 5 years10.16-2.19-464%
Returns for 10 years113.67N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GTLIX24.680.10
+0.41%
Glenmede Disciplined US Eq Ptf InstlShrs
GSPAX20.50N/A
N/A
Goldman Sachs US Eq Div and Premium A
MEIJX54.62N/A
N/A
MFS Value R4
MFWTX18.77N/A
N/A
MFS Global Total Return A
BAFYX12.01N/A
N/A
Brown Advisory Sustainable Sml-Cp Cr Ins